Brief: Immunotech Biopharm Says Unit Entered LP Agreement With Three Entities
Feb 25 (Reuters) - Immunotech Biopharm Ltd 6978.HK :
* UNIT ENTERED LP AGREEMENT WITH TIANJIN JINXIN, SHAOXING
BINHAI
INVESTMENT FUND AND TIANJIN TIANJIAN
* BEIJING YONGTAI'S TOTAL CAPITAL COMMITMENT IN INDUSTRY
FUND AS
LIMITED PARTNER IS RMB50 MILLION
Source text for Eikon: ID:nHKSV3YCj
Further company coverage: 6978.HK
((reuters.briefs@thomsonreuters.com))
Recent news on Immunotech Biopharm
See all newsBrief: Immunotech Biopharm Gets Approval In Sept 2025 For Clinical Translational Application Of Atl In Hainan
Brief: Immunotech Biopharm Receives Notice Of Rejection For Conditional New Drug Application For EAL Dated 27 April 2026
Brief: Trading In Shares Of Immunotech Biopharm Will Be Halted At 1:00 PM On April 28, HKEX Says
Brief: Immunotech Biopharm Posts Loss And Total Comprehensive Expense For Year Attributable Rmb230.8 Million
Brief: Immunotech Biopharm Subscribes To Structured Deposit Product With Investment Value Of RMB50 MLN